The discovery of novel bioactive compounds, together with evidence of pathway-specific effects, highlights the plant’s potential as a source of structurally diverse and pharmacologically relevant metabolites for anticancer research.
Patrícia de Oliveira Figueiredo, O. Kirchhoffer, L. Marcourt et al.· Frontiers in Natural Product...· 0 citations
This work surveyed the literature, major conference proceedings, and expert networks to identify therapies approved, in clinical development, or supported by compelling preclinical data between 2022 and 2025, and focused on small molecules and genetic therapies for conditions in which movement disorders represent a pro...
C. D. de Gusmao, V. Katanaev, Laura Silveira-Moriyama et al.· Movement Disorders· 1 citation
It is demonstrated that overexpression of the wild-type protein mitigates behavioral abnormalities and restores functional neuronal deficits in young adult mice, thereby supporting the development of AAV-mediated gene augmentation strategies to counteract the effects of GNAO1 variants in patients.
Germana Cocozza, T. D’Andrea, M. Di Rocco et al.· Acta Neuropathologica Commun...· 0 citations
It is revealed that BYSL acts as a pivotal downstream mediator of MYC-regulated ribosome biogenesis and promotes hepatocellular carcinoma progression, suggesting that BYSL may represent a potential therapeutic target for hepatocellular carcinoma.
Heyuan Zhao, Hui-Ying Liu, Xia Liu et al.· Cellular Signalling· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.